Nasolabial and cheek wrinkles. R23.8
Conditions
Interventions
Intervention 1: Intervention group: Patients receive 5 ml of pure fat and 5 ml of svf (stromal vascular fraction) using needle number 27 within 7 minutes. Intervention 2: Control group: Patients recei
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: Age under 65 years old Patients satisfaction Middle to deep nasolabial wrinkles
Exclusion criteria
Exclusion criteria: Diabetes melitus Patients with hematologic and coagulation problems Smoking Pregnancy Use of Aspirin Patients with defective immune system
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasolabial and cheek wrinkle severity. Timepoint: Before injection, 3, 6 and 12 months after injection. Method of measurement: Wrinkle Severity Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The degree of tissue healing and homogeneity of facial skin. Timepoint: Before injection, 3, 6 and 12 months after injection. Method of measurement: Skin Homogeneity and Texture ScaleI. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Leila Asadi
Tabriz University of Medical Sciences
Outcome results
None listed